New Study Shows Ozempic and Semaglutide May Lower Risk of Severe Liver Diseases
A nationwide study in Sweden suggests that GLP1 agonists like Ozempic could lower the risk of cirrhosis and liver cancer in individuals with type 2 diabetes and chronic liver disease. This new finding provides a potential life-saving benefit of these medications, offering a new treatment option for preventing severe liver diseases.
Signs of Liver Damage: Foot Pain and Swelling
New Delhi: The liver is a vital organ that performs over 500 functions in the body, including digestion, blood cleaning, immune support, and blood clotting. When the liver is unable to carry out these functions, it may exhibit warning signs…